These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17658474)

  • 1. Identification of TBC7 having TBC domain as a novel binding protein to TSC1-TSC2 complex.
    Nakashima A; Yoshino K; Miyamoto T; Eguchi S; Oshiro N; Kikkawa U; Yonezawa K
    Biochem Biophys Res Commun; 2007 Sep; 361(1):218-23. PubMed ID: 17658474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes.
    Miyazaki M; McCarthy JJ; Esser KA
    FEBS J; 2010 May; 277(9):2180-91. PubMed ID: 20412061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.
    Dibble CC; Elis W; Menon S; Qin W; Klekota J; Asara JM; Finan PM; Kwiatkowski DJ; Murphy LO; Manning BD
    Mol Cell; 2012 Aug; 47(4):535-46. PubMed ID: 22795129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
    Inoki K; Li Y; Zhu T; Wu J; Guan KL
    Nat Cell Biol; 2002 Sep; 4(9):648-57. PubMed ID: 12172553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
    Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
    J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.
    Kwiatkowski DJ
    Cancer Biol Ther; 2003; 2(5):471-6. PubMed ID: 14614311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.
    Garami A; Zwartkruis FJ; Nobukuni T; Joaquin M; Roccio M; Stocker H; Kozma SC; Hafen E; Bos JL; Thomas G
    Mol Cell; 2003 Jun; 11(6):1457-66. PubMed ID: 12820960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7).
    Qin J; Wang Z; Hoogeveen-Westerveld M; Shen G; Gong W; Nellist M; Xu W
    J Biol Chem; 2016 Apr; 291(16):8591-601. PubMed ID: 26893383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits.
    Hoogeveen-Westerveld M; van Unen L; van den Ouweland A; Halley D; Hoogeveen A; Nellist M
    BMC Biochem; 2012 Sep; 13():18. PubMed ID: 23006675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.
    Matthew EM; Hart LS; Astrinidis A; Navaraj A; Dolloff NG; Dicker DT; Henske EP; El-Deiry WS
    Cell Cycle; 2009 Dec; 8(24):4168-75. PubMed ID: 20054236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth.
    Gan B; Yoo Y; Guan JL
    J Biol Chem; 2006 Dec; 281(49):37321-9. PubMed ID: 17043358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control.
    Gan B; Melkoumian ZK; Wu X; Guan KL; Guan JL
    J Cell Biol; 2005 Aug; 170(3):379-89. PubMed ID: 16043512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin.
    Shumway SD; Li Y; Xiong Y
    J Biol Chem; 2003 Jan; 278(4):2089-92. PubMed ID: 12468542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of TSC2 by 14-3-3 binding.
    Li Y; Inoki K; Yeung R; Guan KL
    J Biol Chem; 2002 Nov; 277(47):44593-6. PubMed ID: 12364343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant beta-catenin signaling in tuberous sclerosis.
    Mak BC; Kenerson HL; Aicher LD; Barnes EA; Yeung RS
    Am J Pathol; 2005 Jul; 167(1):107-16. PubMed ID: 15972957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.
    Zhang H; Cicchetti G; Onda H; Koon HB; Asrican K; Bajraszewski N; Vazquez F; Carpenter CL; Kwiatkowski DJ
    J Clin Invest; 2003 Oct; 112(8):1223-33. PubMed ID: 14561707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The variation of AkT/TSC1-TSC1/mTOR signal pathway in hepatocytes after partial hepatectomy in rats.
    Chen P; Yan H; Chen Y; He Z
    Exp Mol Pathol; 2009 Apr; 86(2):101-7. PubMed ID: 19348060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
    Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
    Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR.
    Dere R; Wilson PD; Sandford RN; Walker CL
    PLoS One; 2010 Feb; 5(2):e9239. PubMed ID: 20169078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.